Percutaneous Coronary Angioplasty Compared With Exercise Training in Symptomatic Coronary Artery Disease
1 other identifier
interventional
400
1 country
1
Brief Summary
The purpose of this study is to compare coronary angioplasty with stent implantation with an exercise rehabilitation program in patients with stable coronary artery disease (CAD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 15, 2005
CompletedSeptember 10, 2007
September 1, 2005
September 9, 2005
September 7, 2007
Conditions
Interventions
Eligibility Criteria
You may qualify if:
- Angiographically documented CAD, with at least one coronary artery stenosis of more than 50% in a native segment never subjected to intervention, which is recommended for treatment with percutaneous transluminal coronary angioplasty (PTCA).
- Stable coronary artery disease
- Eligible patients could be asymptomatic or have class I to III angina (Canadian Cardiovascular Society \[CCS\]) with documented myocardial ischemia
- Angina pectoris threshold \> 50 Watt (cycle ergometry)
- Permanent residence should be within 25 km of training facility.
You may not qualify if:
- \< 18 or \> 70 years of age
- Patient currently participating in an exercise training program
- Unstable angina pectoris or myocardial infarction during the last 2 weeks
- Symptoms of CCS class IV
- Exercise limitations due to clinical conditions not related to CAD
- Left ventricular ejection fraction (LVEF) of \< 40%
- Ventricular arrhythmia (Lown Ivb)
- Hemodynamically significant valvular heart disease
- Previous cardiac surgery
- PTCA performed during the last 12 months
- Any major non-cardiac condition that would adversely affect survival during the duration of the study
- Reduced compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Leipzig - Heart Center
Leipzig, 04289, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rainer Hambrecht, Prof.
Heart Center Leipzig - University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 15, 2005
Last Updated
September 10, 2007
Record last verified: 2005-09